The Drug Enforcement Administration and the Substance Abuse and Mental Health Services Administration has extended its COVID-19 pandemic rules for prescribing controlled substances via telemedicine through Dec. 31, 2024. The regulation is effective Nov. 11.
This content is restricted to members.
